For Frontier Drug Discovery Model Teams
Simulation-First Requires
Structured Biological Substrate
Most generative biology teams are scaling model size. Very few are scaling dataset governance. Foundation models fail when gene–compound labels drift, protocols vary, cell-type distributions shift, and perturbation corpora lack representation alignment.
Multi-omics into cross-modal embedding spaces
Gene and chemical feature stores
Ontology-consistent perturbation releases
Embedding stability drift monitoring
Corpus-level release governance
For Multiomics Foundation Model Teams
Heterogeneity Must Be Modeled
RNA-seq averages signal. Single-cell fragments it. ATAC-seq exposes regulatory shifts. Proteomics reshapes interpretation. Concatenation is not alignment.
Ontology-consistent alignment
Stable cell-type indexing
Cross-modal harmonization
Temporal-aware versioning
Explore Oncology Infrastructure
Governed Multiomics Systems
Cell-type stratification
Resolution-aware indexing across releases.
Embedding linkage
Structured cross-modal representation coherence.
Version-controlled manifests
Dataset lineage with sub-cohort quantification.
Ontology drift detection
Agentic harmonization with controlled updates.
For Oncology Foundation & Translational AI Teams
Cancer Is a Moving Target
Variation occurs across subtypes, treatment lines, time, modalities, and institutions. Static snapshots create silent worst-cohort collapse.
Subgroup drift detection
Worst-cohort tracking
Versioned validation
Release gates
Oncology Intelligence Substrate
Multimodal harmonization
WSI, radiology, and omics alignment.
Longitudinal indexing
Treatment-line structured progression modeling.
Robustness quantification
Worst-cohort performance reporting frameworks.
Drift-aware monitoring
Escalation routing and governance artifacts.
Operationalize AI With Governance
Install the AI-native operations layer inside your hospital infrastructure.
Schedule Enterprise Review